Vista Pharmaceuticals Q2 Results

  • BSE: 524711
  • NSE: -
  • ISIN: INE427C01021
  • Sector: Biotechnology & Drugs
BSE
12.10.04 (0.33%)
Volume2.18 K
Updated: Wed 27 Nov, 2024 | 11:56:25
NSE
This stock is not traded on NSE
Today: 11.57
12.30
52-Wk: 10.43
17.89

Q2 Results Highlights

  • Total Income
    ₹2.49 Cr.
    (38.97%)
  • Operating Profit
    ₹-1.01 Cr.
    (4.84%)
  • Profit After Tax
    ₹-0.97 Cr.
    (13.62%)
  • Operating Margin
    -40.34%
    (3.67%)
Note: Comparison is on YoY basis

Quarterly - Vista Pharmaceuticals Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 2.491.98-%3.47-%
Selling/ General/ Admin Expenses Total 0.480.42-%0.45-%
Depreciation/ Amortization 0.180.17-%0.18-%
Other Operating Expenses Total 1.290.52-%0.98-%
Total Operating Expense 3.503.08-%4.82-%
Operating Income -1.01-1.09-%-1.35-%
Net Income Before Taxes -1.25-1.29-%-1.59-%
Net Income -0.97-0.95-%-2.02-%
Diluted Normalized EPS -0.16-0.23-%-0.46-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts